Healthcare


 Mayne Pharma (ASX:MYX) Trading Halt Sparks Interest Amid ASX200 Index Movements

Mayne Pharma (ASX:MYX) Trading Halt Sparks Interest Amid ASX200 Index Movements

May 19, 2025 12:19 PM AEST| By Team Kalkine Media

Highlights,Mayne Pharma enters trading halt awaiting takeover announcement,Proposed Cosette Pharmaceuticals deal values Mayne Pharma at $672 million,Shares paused amid ongoing activity in ASX200 index and ASX dividend stocks,Mayne Pharma Group (ASX:M...

 CSL and Pro Medicus: What These Two S&P/ASX200 Stocks Reveal About Healthcare Potential

CSL and Pro Medicus: What These Two S&P/ASX200 Stocks Reveal About Healthcare Potential

May 19, 2025 11:51 AM AEST| By Team Kalkine Media

Highlights,CSL and Pro Medicus draw renewed attention in the S&P/ASX200,PME shares soar over 140% from 52-week lows,CSL’s dividend yield surpasses historical average,Within the ever-evolving healthcare landscape, CSL Ltd (ASX:CSL) and Pro Medicus Ltd...

 Mayne Pharma Faces Strategic Turning Point Amid Cosette Bid – What It Means for ASX200 Investors

Mayne Pharma Faces Strategic Turning Point Amid Cosette Bid – What It Means for ASX200 Investors

May 19, 2025 10:46 AM AEST| By Team Kalkine Media

Highlights,Mayne Pharma responds to a $672 million bid from Cosette Pharmaceuticals,Trading halt requested pending formal announcement,Shares recover after independent valuation review by Deloitte,Mayne Pharma (ASX:MYX) has entered a trading halt as...

 Is Trajan Group Keeping Pace with the ASX All Ordinaries?

Is Trajan Group Keeping Pace with the ASX All Ordinaries?

May 18, 2025 10:30 AM AEST| By Team Kalkine Media

Is Trajan Group Keeping Pace with the ASX All Ordinaries?

 Is Ramsay Health Care's Valuation Reflecting Its ASX Healthcare Position?

Is Ramsay Health Care's Valuation Reflecting Its ASX Healthcare Position?

May 18, 2025 10:30 AM AEST| By Team Kalkine Media

Is Ramsay Health Care's Valuation Reflecting Its ASX Healthcare Position?

 Is Trajan Group's Leadership Aligned With Shareholder Interests on the ASX?

Is Trajan Group's Leadership Aligned With Shareholder Interests on the ASX?

May 17, 2025 10:33 AM AEST| By Team Kalkine Media

Is Trajan Group's Leadership Aligned With Shareholder Interests on the ASX?

 Is Beamtree Reflecting Sector Trends on the ASX Healthcare Index?

Is Beamtree Reflecting Sector Trends on the ASX Healthcare Index?

May 17, 2025 10:32 AM AEST| By Team Kalkine Media

Is Beamtree Reflecting Sector Trends on the ASX Healthcare Index?

 Can Neuren Pharmaceuticals Align with ASX Healthcare Sector Metrics?

Can Neuren Pharmaceuticals Align with ASX Healthcare Sector Metrics?

May 17, 2025 10:32 AM AEST| By Team Kalkine Media

Can Neuren Pharmaceuticals Align with ASX Healthcare Sector Metrics?

 Is Telix Pharmaceuticals Financially Stable in the ASX Healthcare Sector?

Is Telix Pharmaceuticals Financially Stable in the ASX Healthcare Sector?

May 16, 2025 04:32 PM AEST| By Team Kalkine Media

Is Telix Pharmaceuticals Financially Stable in the ASX Healthcare Sector?

 CSL’s 2025 Dip: What the ASX200 Healthcare Giant Signals About Long-Term Value

CSL’s 2025 Dip: What the ASX200 Healthcare Giant Signals About Long-Term Value

May 16, 2025 10:59 AM AEST| By Team Kalkine Media

Highlights,CSL’s share price sees a 15.2% decline in 2025, prompting closer scrutiny,Healthcare sector shows resilience through economic cycles,CSL’s dividend yield now exceeds its 5-year average,CSL Limited (ASX:CSL), one of Australia’s most promine...

 Could Mayne Pharma’s Takeover Evaluation Shift Sentiment on ASX Healthcare Index?

Could Mayne Pharma’s Takeover Evaluation Shift Sentiment on ASX Healthcare Index?

May 15, 2025 09:57 PM AEST| By Team Kalkine Media

Could Mayne Pharma’s Takeover Evaluation Shift Sentiment on ASX Healthcare Index?

 How Is This ASX 200 (XJO) Healthcare Stock Positioned in the Global Medical Device Market?

How Is This ASX 200 (XJO) Healthcare Stock Positioned in the Global Medical Device Market?

May 15, 2025 06:10 PM AEST| By Team Kalkine Media

How Is This ASX 200 (XJO) Healthcare Stock Positioned in the Global Medical Device Market?

 Is HiTiQ Limited (ASX:HIQ) Expanding Its Tech Reach With A Capital Raise?

Is HiTiQ Limited (ASX:HIQ) Expanding Its Tech Reach With A Capital Raise?

May 15, 2025 05:33 PM AEST| By Team Kalkine Media

Is HiTiQ Limited (ASX:HIQ) Expanding Its Tech Reach with a Capital Raise?

 Is the ASX Biotech Sector Seeing a Shift with Immutep's Lung Cancer Trial Progress?

Is the ASX Biotech Sector Seeing a Shift with Immutep's Lung Cancer Trial Progress?

May 15, 2025 04:13 PM AEST| By Team Kalkine Media

Is the ASX Biotech Sector Seeing a Shift with Immutep's Lung Cancer Trial Progress?

 Is the ASX200 Biotechnology Sector Responding to Amplia’s Clinical Progress?

Is the ASX200 Biotechnology Sector Responding to Amplia’s Clinical Progress?

May 15, 2025 02:30 PM AEST| By Team Kalkine Media

Is the ASX200 Biotechnology Sector Responding to Amplia’s Clinical Progress?

 What Are the Latest Developments in HITIQ on the ASX All Ordinaries and ASX Small Industrials Index?

What Are the Latest Developments in HITIQ on the ASX All Ordinaries and ASX Small Industrials Index?

May 15, 2025 02:25 PM AEST| By Team Kalkine Media

What Are the Latest Developments in HITIQ on the ASX All Ordinaries and ASX Small Industrials Index?

 What’s Driving IME in the Healthcare Tech Sector? Key Moves Within ASX 100

What’s Driving IME in the Healthcare Tech Sector? Key Moves Within ASX 100

May 15, 2025 02:07 PM AEST| By Team Kalkine Media

Highlights,ImExHS Limited has announced the quotation of additional fully paid ordinary securities.,The company operates in the healthcare technology sector, providing imaging software solutions.,IME is listed on the ASX with a focus on expanding liq...

 Is (ASX:MSB) Advancing In Biotech with FDA Orphan Drug Approval On ASX 300 and All Ordinaries?

Is (ASX:MSB) Advancing In Biotech with FDA Orphan Drug Approval On ASX 300 and All Ordinaries?

May 15, 2025 01:08 PM AEST| By Team Kalkine Media

Highlights:,Mesoblast,receives,FDA,orphan,drug,designation,for,Ryoncil.,The,designation,grants,marketing,exclusivity,in,the,United,States.,Applicable,to,treatment,for,acute,graft,versus,host,disease,in,children.,Mesoblast,Limited (,ASX,:,MSB,),operat...

 Is (ASX:EPN) Strengthening Capital Structure Through Loan Notes On The ASX All Ordinaries And ASX 300?

Is (ASX:EPN) Strengthening Capital Structure Through Loan Notes On The ASX All Ordinaries And ASX 300?

May 15, 2025 12:45 PM AEST| By Team Kalkine Media

Is (ASX:EPN) Strengthening Capital Structure Through Loan Notes on the ASX All Ordinaries and ASX 300?

 Why Is Mesoblast’s FDA Approval Gaining Attention on the ASX200 and NASDAQ?

Why Is Mesoblast’s FDA Approval Gaining Attention on the ASX200 and NASDAQ?

May 15, 2025 11:30 AM AEST| By Team Kalkine Media

Why Is Mesoblast’s FDA Approval Gaining Attention on the ASX200 and NASDAQ?

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.